Federated Hermes
TNGX icon

Federated Hermes’s Tango Therapeutics TNGX Stock Holding History

Federated Hermes’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.41K Sell
354
-8
-2% -$111 ﹤0.01% 1859
2025
Q4 		$3.21K Hold
362
– – ﹤0.01% 1933
2025
Q3 		$3.04K Hold
362
– – ﹤0.01% 1992
2025
Q2 		$1.85K Sell
362
-7,221
-95% -$17.9K ﹤0.01% 1961
2025
Q1 		$10.4K Buy
+7,583
New +$18.6K ﹤0.01% 1798
2024
Q2 		– Sell
-67,115
Closed -$533K – 2135
2024
Q1 		$533K Buy
67,115
+66,959
+42,922% +$718K ﹤0.01% 1308
2023
Q4 		$1.54K Buy
+156
New +$1.35K ﹤0.01% 1949
2023
Q2 		– Sell
-412
Closed -$1.63K – 2221
2023
Q1 		$1.63K Buy
+412
New +$2.39K ﹤0.01% 2015

Other funds holding TNGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Federated Hermes's TNGX Position: Q1 2026 in Review

Federated Hermes reduced its Tango Therapeutics (TNGX) stake by 2.2% in Q1 2026, selling an estimated $111 and leaving 354 shares worth $7.41K. The position accounts for ﹤0.01% of the portfolio, ranked #1859.

Federated Hermes first reported a position in TNGX in Q1 2023 and has held it in 8 quarters since. The position peaked at $533K in Q1 2024. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • Federated Hermes held 354 shares of Tango Therapeutics worth $7.41K as of Q1 2026.
  • Federated Hermes sold 8 Tango Therapeutics shares in Q1 2026, an estimated $111.
  • Tango Therapeutics made up ﹤0.01% of Federated Hermes's portfolio in Q1 2026, its #1859 holding.
  • Federated Hermes first reported a position in Tango Therapeutics in Q1 2023 and has held it in 8 quarters since.
  • Federated Hermes's Tango Therapeutics position peaked at $533K in Q1 2024.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.